stiripentol has been researched along with Status Epilepticus in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chancharme, L; Chemaly, N; Chiron, C; Nabbout, R | 1 |
| Fujioka, T; Kato, D; Madokoro, Y; Matsukawa, N; Mizuno, M; Terada, K; Toyoda, T; Uchida, Y | 1 |
| Eschbach, K; Knupp, KG | 1 |
| Grosenbaugh, DK; Mott, DD | 2 |
| Auvin, S; Desnous, B; Dournaud, P; Dupuis, N; Gressens, P; Lebon, S; Lecointe, C | 1 |
| Knake, S; Kortland, LM; Rosenow, F; Strzelczyk, A | 1 |
| Kato, D; Matsukawa, N; Ohkita, K; Oomura, M; Toyoda, T; Uchida, Y; Ueki, Y | 1 |
| Chiron, C; Dulac, O; Kröll-Seger, J; Portilla, P | 1 |
1 review(s) available for stiripentol and Status Epilepticus
| Article | Year |
|---|---|
Stiripentol for the treatment of seizures in Dravet syndrome.
Topics: Animals; Anticonvulsants; Child; Dioxolanes; Drug Approval; Epilepsies, Myoclonic; Humans; Seizures; Status Epilepticus | 2019 |
8 other study(ies) available for stiripentol and Status Epilepticus
| Article | Year |
|---|---|
Initiating stiripentol before 2 years of age in patients with Dravet syndrome is safe and beneficial against status epilepticus.
Topics: Anticonvulsants; Child, Preschool; Epilepsies, Myoclonic; Female; Humans; Infant; Male; Retrospective Studies; Seizures; Status Epilepticus; Treatment Outcome | 2023 |
Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity.
Topics: Adult; Aged; Anticonvulsants; Dioxolanes; Drug Eruptions; Female; Humans; Male; Middle Aged; Retrospective Studies; Seizures; Status Epilepticus; Young Adult | 2018 |
Stiripentol in refractory status epilepticus.
Topics: Animals; Anticonvulsants; Benzodiazepines; Dioxolanes; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, GABA-A; Status Epilepticus | 2013 |
Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain.
Topics: Age Factors; Animals; Anticonvulsants; Brain; Brain Chemistry; Dioxolanes; Disease Models, Animal; Male; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, GABA-A; Seizures; Status Epilepticus | 2013 |
Stiripentol for the treatment of super-refractory status epilepticus.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Critical Care; Dioxolanes; Dose-Response Relationship, Drug; Drug Resistant Epilepsy; Electroencephalography; Female; Humans; Male; Status Epilepticus; Treatment Outcome | 2015 |
Combination of ketogenic diet and stiripentol for super-refractory status epilepticus: A case report.
Topics: Anticonvulsants; Combined Modality Therapy; Diet, Ketogenic; Dioxolanes; Drug Resistant Epilepsy; Female; Humans; Status Epilepticus; Young Adult | 2017 |
Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus.
Topics: Animals; Anticonvulsants; Benzodiazepines; Dioxolanes; Disease Models, Animal; Drug Synergism; Inhibitory Postsynaptic Potentials; Male; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Status Epilepticus; Synaptic Transmission | 2013 |
Topiramate in the treatment of highly refractory patients with Dravet syndrome.
Topics: Anticonvulsants; Dioxolanes; Drug Therapy, Combination; Electroencephalography; Epilepsies, Myoclonic; Epilepsy, Tonic-Clonic; Female; Follow-Up Studies; Fructose; Humans; Infant; Male; Retrospective Studies; Seizures, Febrile; Status Epilepticus; Topiramate; Treatment Outcome | 2006 |